Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5965)	10/13/1998 6:10:00 PM
From: Hesham	Respond to of 9523

Q3) On a pro-forma basis, reflecting last year's business segments and tax rate, what were third quarter 1998 diluted earnings per share excluding divestiture gains and unusual and non-recurring items? A3) On a pro-forma basis, reflecting last year's business segments and tax rate, third-quarter 1998 diluted earnings per share excluding divestiture gains and unusual and non-recurring items would have been $.56. This includes last year's third-quarter MTG contribution from operations ($.02) and uses the lower effective tax rate of the third quarter of 1997 ($.03).